Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Reactive Biosciences logo — Harnessing the unique properties of boron to discover impact...

Reactive Biosciences

Harnessing the unique properties of boron to discover impactful medicines.

Founded 2021 United States United States 8 employees Debt Financing Total: $43.03M Biotechnology, Health Care +1

General Information

Company Name Reactive Biosciences
Founded Year 2021
Location United States United States
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Reactive Biosciences. To contact Reactive Biosciences, visit reactivebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Reactive Biosciences compare?

A PDF of Reactive Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Reactive Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Reactive Biosciences

Reactive Biosciences is a biotechnology company based in the United States, established in 2015. The company's slogan "Harnessing the unique properties of boron to discover impactful medicines" encapsulates its mission to leverage boron's properties for the development of impactful medications in the Biotechnology and Health Care sectors. Reactive Biosciences recently secured a significant $4.00M Debt Financing investment on 22 June 2023, highlighting investor confidence in the company's vision and potential. Although the specific investors involved in this funding round are not disclosed, this injection of capital signifies external interest and support for Reactive Biosciences' innovative approach. The company's commitment to cutting-edge research and the development of novel medications positions it as an intriguing prospect for venture capital consideration. Reactive Biosciences' dedication to harnessing boron's unique properties for medical advancements presents a compelling investment opportunity in the evolving landscape of healthcare innovation.

Business keywords: Boron-based discovery platform, Medicine discovery, Innovative drug development, Therapeutics exploration, Undruggable areas, Partnerships, Transformative medicine discovery, Research and development, Medical innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $4.00M -
22 Jun 2023
Venture Round $23.50M -
13 Sep 2022
Venture Round $2.00M -
03 Jan 2020
Debt Financing $3.00M -
26 Feb 2019
Series A $10.53M -
22 Mar 2017

Reactive Biosciences Alternatives & Competitors

View All Alternatives
Reactive Biosciences vs
Meddenovo Drug Design
Meddenovo Drug Design France

Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide t...

Seed
10 employees
AI, Biopharma
Reactive Biosciences vs
DELIVER Therapeutics, Inc.
DELIVER Therapeutics, Inc. United States

Applying high throughput screening technologies to deliver novel therapeutics

7 employees
Biopharma, Biotechnology
Reactive Biosciences vs
TenSixty Biosciences
TenSixty Biosciences

We're on a mission to create transformative drugs that will save lives and redefine oncology

Non Equity Assistance
6 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Reactive Biosciences

Harnessing the unique properties of boron to discover impactful medicines.
Reactive Biosciences was founded in 2021.
Reactive Biosciences is headquartered in United States.
Reactive Biosciences operates in Biotechnology, Health Care and Life Sciences. Its work centres on Boron-based discovery platform, Medicine discovery, Innovative drug development and Therapeutics exploration.
Reactive Biosciences has approximately 8 employees.
Reactive Biosciences has completed 5 funding rounds, raising a total of $43.03M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Reactive Biosciences include Meddenovo Drug Design, DELIVER Therapeutics, Inc., TenSixty Biosciences, Anavo Therapeutics BV, Atomwise. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reactive Biosciences and Meddenovo Drug Design are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Reactive Biosciences, https://bouncewatch.com/company/reactive-biosciences, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout